308.48MMarket Cap-6.12P/E (TTM)
3.200High3.050Low863.97KVolume3.200Open3.220Pre Close2.69MTurnover0.92%Turnover RatioLossP/E (Static)98.87MShares5.80052wk High-5.13P/B294.07MFloat Cap2.24052wk Low--Dividend TTM94.25MShs Float20.696Historical High--Div YieldTTM4.66%Amplitude0.618Historical Low3.114Avg Price1Lot Size
Aquestive Therapeutics Stock Forum
They have done over 700 infusions without any significant side effects. They will continue to do these at infusion centers just to be extra safe so treatment is available if there ever was a bad reaction.
Big things happening CAPR will be over 20+ soon
Apextradez where winning happens
XHLD alerted at .64c - think about that do you like HUGE profifs then...
$Aquestive Therapeutics (AQST.US)$
nfa
$Aquestive Therapeutics (AQST.US)$
nfa
share your thoughts & ideas explain why 2025 will be amazing several break free and run
apextradez Wins so can you
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
Thursday, 19th December at 8:00 am
WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery te...
1 min ago
Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms Nda Submission Guidance for Anaphylm™ (Epinephrine) Sublingual Film
Doesn't make sense to me?
No comment yet